Cargando...
Oxiperomide in tardive dyskinesia.
Tardive dyskinesia can be suppressed by dopaminergic receptor blockers, but often at the cost of a reciprocal increase in Parkinsonism. Oxiperomide, a dopaminergic antagonist that has been shown to reduce levodopa-induced dyskinesias without producing an equal aggravation of Parkinsonism, was evalua...
Guardado en:
| Publicado en: | J Neurol Neurosurg Psychiatry |
|---|---|
| Autores principales: | , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
BMJ Publishing Group
1980
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC490519/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/7373324/ https://ncbi.nlm.nih.govhttps://doi.org/10.1136/jnnp.43.3.264 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|